GLOW Stack Research Guide: BPC-157 + TB-500 + GHK-Cu
GLOW combines three of the most-studied recovery peptides in one vial: BPC-157, TB-500, and GHK-Cu.
Component mechanisms
BPC-157 — pentadecapeptide studied for VEGFR2 upregulation, nitric-oxide modulation, and growth-hormone receptor sensitization in tendon and ligament repair models.
TB-500 — Thymosin β-4 fragment (residues 17–23) studied for G-actin sequestration, cell migration, and angiogenic signaling.
GHK-Cu — copper-binding tripeptide studied for matrix metalloproteinase modulation, collagen synthesis, and antioxidant enzyme activity.
Sourcing & purity
Research-grade material should be ≥99% pure by HPLC with peptide content confirmed via mass spectrometry. Redline Bio material ships with batch documentation; independent third-party COAs are published on the lab reports page as testing returns.
Compliance reminder
Sold and distributed for laboratory research use only. Not approved by the FDA for human consumption, diagnosis, treatment, or cure of any disease. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.
Frequently asked questions
Why combine these three?
BPC-157 is studied for VEGFR2 and NO-mediated tissue repair, TB-500 for actin sequestration and cell migration, and GHK-Cu for copper-dependent matrix remodeling and antioxidant signaling. Together they cover three complementary arms of the wound-healing literature.